Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques
about
Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.Motion Compensated Ultrasound Imaging Allows Thermometry and Image Guided Drug Delivery Monitoring from Echogenic Liposomes.MR-guided focused ultrasound surgery, present and futureCombination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.Characterization of restricted diffusion in uni- and multi-lamellar vesicles using short distance iMQCsAn imaging-driven model for liposomal stability and circulation.Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablationImproving conformal tumour heating by adaptively removing control points from waveform diversity beamforming calculations: a simulation study.Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate.Penetration of lysozyme and cytochrome C in lipid bilayer: fluorescent study.Localised drug release using MRI-controlled focused ultrasound hyperthermia.Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.Enhanced Drug Delivery to the Skin Using LiposomesNucleic acid therapeutics: concepts for targeted delivery to solid tumorsRADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICSMaghemite/poly(d,l-lactide-co-glycolyde) composite nanoplatform for therapeutic applicationsMultifunctional antitumor magnetite/chitosan-l-glutamic acid (core/shell) nanocomposites
P2860
Q30375252-8BA5D446-D8C2-43DF-B8F8-D26EF67B1AA1Q30375864-C265C5B7-E086-40F1-B0D8-41E6122D3594Q30417756-81B26C68-D70A-4304-812E-918792027B7DQ30494208-89708E84-DED0-40B7-B0E5-C25C6B9EFDA5Q30565398-B6BEE683-3ED6-46CA-8A9E-C791D9C76BF1Q33839139-A7650170-0F1D-463F-8126-FB713E8C0B8BQ34217254-F04F182F-F52F-43FD-B0BD-51F51CD74298Q37789749-B6FC803A-0424-4478-BA9A-860878320F1EQ42126581-E5DEFABE-D669-494D-88A4-52E2594C8844Q44049302-54BDFBB8-34DF-47CB-976D-EA82AB9AF56AQ50246623-5A8C2A18-29E4-48C9-8C13-17F5B0017634Q50883487-864FAB04-A9BE-4B88-B361-1A801249C0B7Q57176803-86F00F94-067D-43D1-B362-3691EFD1E714Q57372842-B2D7C789-EF64-4EFA-908C-E03D2A85E7DBQ57832750-CFC3D680-7554-460B-8C70-13BD139C05C0Q58854679-F7201746-F21D-46E7-8E5B-E135C46E75E0Q58854688-FF3DAECC-08BA-4B5E-9BE0-374F2BF14CC6
P2860
Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale for and measurement ...... on-invasive imaging techniques
@en
Rationale for and measurement ...... n-invasive imaging techniques.
@nl
type
label
Rationale for and measurement ...... on-invasive imaging techniques
@en
Rationale for and measurement ...... n-invasive imaging techniques.
@nl
prefLabel
Rationale for and measurement ...... on-invasive imaging techniques
@en
Rationale for and measurement ...... n-invasive imaging techniques.
@nl
P2093
P2860
P1476
Rationale for and measurement ...... on-invasive imaging techniques
@en
P2093
Benjamin L Viglianti
David Needham
Jessica A Tashjian
Mark W Dewhirst
P2860
P356
10.1080/02656730701840147
P577
2008-02-01T00:00:00Z